Healthcare systems have sophisticated legal and regulatory functions. Their state legislative relationships are often an afterthought. That gap is expensive — and increasingly consequential as state capitals become the primary venue for healthcare policy decisions that used to be made in Washington.
There is a specific pattern that repeats in healthcare government affairs with enough regularity to qualify as an industry-wide structural problem.
A major health system has a well-resourced legal department. It has a robust compliance function. It has a government affairs team that monitors federal legislation and engages with CMS and HHS on regulatory matters. It has a communications team that manages media relationships and community presence.
What it frequently does not have is a serious, sustained, strategically managed relationship with the state legislature and the governor’s office in its primary operating state.
This is not a criticism of any particular organization. It is a reflection of where the healthcare industry has historically concentrated its government affairs investment. Federal policy — Medicare reimbursement rates, the Affordable Care Act and its successors, FDA regulation, federal research funding — has commanded the majority of attention and resources for decades.
That calculation is increasingly wrong. And the healthcare systems that have not recalibrated it are accumulating risk at the state level that their federal-focused GR infrastructure is not equipped to address.
The shift to state capitals
The practical reality of American healthcare policy is that state capitals have become the venue where the most consequential near-term decisions are being made. This is not a temporary shift. It reflects the structural reality of a federal system in which congressional gridlock on healthcare has persisted long enough that states have filled the vacuum with their own policy initiatives.
Certificate of Need laws — the regulatory frameworks that govern whether health systems can build new facilities, add beds, or launch new service lines — are set and modified at the state level. Medicaid expansion decisions, Medicaid managed care contract structures, and Medicaid reimbursement rates are state-level decisions that can move billions of dollars in health system revenue. Scope of practice legislation determines what nurse practitioners, physician assistants, and other clinical professionals can do, directly affecting workforce economics and care delivery models. Price transparency and surprise billing requirements are increasingly being layered at the state level on top of federal frameworks.
Every one of these policy areas is determined primarily in state capitals. And in every one of them, the organizations that have invested in sustained, relationship-based state legislative engagement are consistently better positioned than those that show up when a specific bill threatens them.
THE REACTIVE TRAP
The most common pattern in healthcare state legislative affairs is reactive engagement. A bill appears that threatens a specific program or revenue stream. The government affairs team mobilizes. Lobbyists are retained or activated. Meetings are scheduled. Arguments are made. Sometimes this works. But a health system that is showing up to a legislative relationship for the first time when it needs something has already lost most of the relationship capital that the conversation requires. The legislature has seen this pattern before. It does not look like partnership. It looks like a transaction.
What certificate of need fights reveal
Certificate of Need proceedings are among the most instructive windows into the quality of a health system’s state legislative relationships. CON frameworks vary significantly by state, but the dynamic is consistent: health systems seeking to expand their facilities or service lines must navigate an approval process that is simultaneously administrative, regulatory, and political.
The administrative and regulatory dimensions of a CON proceeding have formal rules and procedural requirements that legal and regulatory teams can navigate. The political dimension — which legislators care about this facility, which ones are skeptical of this health system’s community role, which ones have constituents who are actively opposed — requires a different kind of intelligence that most health system GR functions are not systematically building.
The health systems that consistently win complex CON proceedings are not necessarily the ones with the best technical applications. They are the ones whose legislative relationships mean that the political environment around the proceeding has been shaped before the application is filed. Community benefit agreements are in place. Workforce commitments are documented. Key legislators have been briefed, heard concerns, and in some cases are actively supportive.
The ones who lose are often the ones who filed first-rate applications into a political environment they did not understand and had not invested in.
The health systems that consistently win complex CON proceedings are not the ones with the best technical applications. They are the ones whose legislative relationships shaped the political environment before the application was filed.
Medicaid policy and the revenue exposure most systems underestimate
For most major health systems, Medicaid represents a substantial and structurally important revenue stream. The reimbursement rates, managed care contract structures, and program design decisions that determine how much a health system receives for Medicaid patients are made at the state level — through budget negotiations, legislative action, and administrative rulemaking that happens on a schedule that does not pause for health system readiness.
The health systems with strong state legislative relationships have advance visibility into how the budget process is developing, which legislators are pushing for rate changes, and what the governor’s office priorities are before proposals become public. They have relationships with appropriations committee staff who can signal when a Medicaid line item is in play.
The ones without those relationships read about proposed Medicaid cuts in the trade press. Then they mobilize. Then they discover that the budget has already been moving in a particular direction for months, that the key relationships were cultivated by other stakeholders, and that their window to influence the outcome is narrower than it should be.
THE REVENUE MATH
A health system with significant Medicaid exposure that has not invested in sustained state legislative relationships is carrying undisclosed political risk on a major revenue line. A five percent change in Medicaid reimbursement rates can move tens of millions of dollars in health system revenue. That risk is not random. It is substantially affected by whether the system has the relationships and the presence in the legislative process to defend its interests when the budget is being written.
What a real state legislative strategy looks like
A health system with a genuine state legislative strategy is doing several things that most systems are not doing systematically.
It has mapped the legislative landscape in its primary operating states — not just who represents the districts where its facilities sit, but who chairs the relevant committees, who the governor’s health policy advisors are, which legislators are genuinely engaged on healthcare issues versus which ones defer to their party leadership, and which community and advocacy organizations have relationships with the legislators who matter most.
It has a year-round engagement calendar that is not driven by the legislative session. The relationships that are useful when a bill is in motion are built in the months when nothing is in motion. Site visits. Community events. Briefings on capital investments and workforce development. The consistent presence that signals partnership rather than transaction.
It has early warning infrastructure. Monitoring of pre-filed legislation, committee assignment patterns, budget process developments, and governor’s office priority signals — so that the system is never in the position of reading about a threat to its interests for the first time in the trade press.
And it has a coalition architecture — relationships with employer groups, labor organizations, patient advocacy groups, and community health organizations that can independently reinforce the health system’s legislative arguments from angles that the system itself cannot occupy. Because a health system arguing for its own reimbursement rates is a health system arguing for its own finances. The same argument, made by a patient advocacy coalition and an employer group and a labor union and a community health organization, looks structurally different to a legislator.
The cross-industry lesson
Healthcare is not unique in this dynamic. Technology companies entering regulated markets have made versions of the same mistake — concentrating government affairs investment at the federal level and underinvesting in state-level relationships until a state proceeding or legislative action creates a crisis. Financial services companies have discovered that state attorneys general and state insurance commissioners make decisions that matter enormously to their business, often without the sustained engagement that federal regulators receive.
The pattern is consistent across industries: organizations that treat state legislative relationships as reactive, transactional, or supplementary to their federal government affairs investment consistently find themselves poorly positioned when state-level decisions turn consequential.
The organizations that treat state legislative relationships as a strategic asset — built year-round, mapped carefully, maintained consistently — find that they are rarely surprised by state-level developments and consistently better positioned when the consequential moments arrive.
That is not a coincidence. It is the compounding return on a specific kind of government affairs investment that most organizations have not made a priority.
